Overview
Rasanjeet Singh is a Hematologist practicing medicine in Novi, Michigan.
His clinical expertise encompasses Rhabdoid Tumor, Spinal Tumor, and Pseudotumor Cerebri Syndrome.
He is actively involved in clinical research, co-authoring 4 peer reviewed articles.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
26850 Providence Pkwy Ste 375, Novi, MI 48374
22301 Foster Winter Dr Fl 3RD, Southfield, MI 48075
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
C. S. Mott Children's Hospital
Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is board certified in Hematology.
Karmanos Cancer Center
Jeffrey Zonder is a Hematologist practicing medicine in Detroit, Michigan. Dr. Zonder is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Vertebroplasty.
Karmanos Cancer Center
Hirva Mamdani is a Hematologist practicing medicine in Detroit, Michigan. She has been practicing medicine for over 17 years. Dr. Mamdani is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma.
Frequently Asked Questions about Dr. Rasanjeet Singh
How do I make an appointment with Dr. Rasanjeet Singh?
You can book an appointment with Dr. Rasanjeet Singh by calling their office at 248-849-7780. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Rasanjeet Singh a top-rated expert for Rhabdoid Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rasanjeet Singh is classified as an Experienced expert for Rhabdoid Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Rasanjeet Singh specialize in?
While Dr. Rasanjeet Singh is a Hematology, they have specific expertise in Rhabdoid Tumor, Spinal Tumor, and Pseudotumor Cerebri Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Rasanjeet Singh participate in research or clinical trials?
Yes. Dr. Rasanjeet Singh has published 4 articles and abstracts on conditions like Rhabdoid Tumor. You can view a list of Dr. Rasanjeet Singh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Rasanjeet Singh accept my insurance?
Dr. Rasanjeet Singh accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 248-849-7780 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Pseudotumor Cerebri SyndromeDr. Singh isExperienced. Learn about Pseudotumor Cerebri Syndrome.
- Rhabdoid TumorDr. Singh isExperienced. Learn about Rhabdoid Tumor.
- Spinal TumorDr. Singh isExperienced. Learn about Spinal Tumor.